Left ventricular hypertrophy and other cardiac risk factors in migraineurs

Nina Zaproudina1,2, Teemu J Niiranen3,4, Verneri Anttila5,6,7

  • 1Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Insights

Migraine is linked to cardiovascular risks like high blood pressure and left ventricular hypertrophy. These findings suggest a potential role for left ventricular hypertrophy in the connection between migraine and cardiovascular events.

Area of Science:

  • Cardiology
  • Neurology
  • Epidemiology

Background:

  • The relationship between cardiovascular risk factors and cardiovascular diseases in individuals with migraine is not fully understood.
  • Existing research requires further investigation into the specific mechanisms linking migraine to cardiovascular health.

Purpose of the Study:

  • To investigate the associations between migraine and various cardiovascular risk factors.
  • To explore novel cardiovascular risk predictors in the context of migraine.

Main Methods:

  • Utilized data from the Finnish Health 2000 Survey (BRIF8901), including 5737 adults aged 30+.
  • Analyzed 488 participants reporting migraine using logistic regression.
  • Included conventional cardiovascular risk factors, educational attainment, left ventricular hypertrophy, and hemoglobin A1c in the analysis.

Main Results:

  • Migraine was associated with female sex (OR=3.75), lower age (B=0.99), lower high-density lipoprotein cholesterol (OR=1.23), higher diastolic blood pressure (OR=1.31), and left ventricular hypertrophy (OR=1.32).
  • The likelihood of left ventricular hypertrophy increased with migraine frequency.

Conclusions:

  • Left ventricular hypertrophy may mediate the link between migraine and cardiovascular events, potentially due to migraine-related hypertension and dyslipidemia.
  • Further research is warranted to confirm these findings and elucidate the underlying mechanisms.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
130
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
153
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
174
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.8K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
131
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
113